Anbex Inc.

St. George, UT

UEI
Y7EJCKML9FW7
CAGE
1XZ60
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
1812 W Sunset Blvd 1a 618, St. George, UT 84770, USA
Website
anbex.com
Founded
1982
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Anbex Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
4571835697 ! Iosat 130 MG tablet 14S Contract · SPE2D326F117S Medical Supply Chain $413
4571591335 ! Iosat 130 MG tablet 14S Contract · SPE2D326F056Q Medical Supply Chain $2,475
4571542362 ! Iosat 130 MG tablet 14S Contract · SPE2D326F034Y Medical Supply Chain $22,853
4570616737 ! Iosat 130 MG tablet 14S Contract · SPE2D326F4292 Medical Supply Chain $4,950
8511569347 ! Other medical Contract · SPE2D025F0592 Medical Supply Chain $335,028

About Anbex Inc.

Anbex Inc., a for-profit Subchapter S corporation based in St. George, Utah, manufactures and supplies potassium iodide tablets and related pharmaceutical products to the federal government as a prime contractor under full-and-open competition across all recent awards.

Anbex operates almost exclusively as a single-customer supplier. The Defense Logistics Agency Troop Support Medical accounts for 318 of 357 total awards (89% of the award count) and $3.52 billion of the $3.54 billion combined potential value (99.4% of dollars). This concentration reflects Anbex's dominant role as the primary potassium iodide tablet supplier for the federal medical supply chain. The vendor holds a $3.5 billion indefinite delivery contract with DLA Troop Support Medical running through September 2030, which serves as the parent vehicle for the overwhelming majority of work. Recent representative delivery orders include a $4,950 order for IOSAT 130 mg tablets awarded January 23, 2026; a $335,028 order for other medical supplies awarded September 12, 2025; and a $192,782 order for other medical products awarded September 22, 2022, all under the same DLA IDC. The second-largest customer, the Department of Health and Human Services Office of the Assistant Secretary for Administration, accounts for only 19 awards valued at $9.3 million combined. Anbex has also worked with the Nuclear Regulatory Commission, the Department of Veterans Affairs, the Department of State, and the Centers for Disease Control and Prevention on smaller awards.

Work is performed at Anbex's facilities in St. George, Utah and Williamsburg, Virginia. The vendor's NAICS footprint centers on medicinal and botanical manufacturing (190 awards) and pharmaceutical preparation manufacturing (143 awards), with 346 of 357 awards classified under Drugs and Biologicals PSC. Anbex has not competed under set-aside categories in the recent award record; all procurement has been full-and-open.

Activity has declined year over year from a peak of 39 awards in 2022 to 16 awards in 2024 and 9 awards in 2025, suggesting a shift in DLA ordering patterns toward fewer, larger delivery orders rather than smaller ones. The combined value of awards with ultimate completion dates in the next twenty-four months totals $335 thousand, indicating minimal near-term recompete exposure. Combined dollars obligated across all 357 awards stands at $22.3 million against $3.54 billion in combined potential value, reflecting the firm-fixed-price delivery-order structure under which DLA issues orders but does not obligate the full ceiling value upfront. Anbex has maintained federal contractor registration since April 2002.

Quick answers

What is Anbex Inc.'s UEI?

Anbex Inc.'s Unique Entity ID (UEI) in SAM.gov is Y7EJCKML9FW7.

What is Anbex Inc.'s CAGE code?

Anbex Inc.'s CAGE code is 1XZ60.

What is Anbex Inc.'s primary NAICS code?

Anbex Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Anbex Inc. located?

Anbex Inc.'s physical address in SAM.gov is 1812 W Sunset Blvd 1a 618, St. George, UT 84770, USA.

Is Anbex Inc. registered in SAM.gov?

Yes. Anbex Inc.'s SAM.gov registration is active through May 28, 2027.

What is Anbex Inc.'s most recent federal award?

Anbex Inc.'s most recent federal contract award is 4571835697 ! Iosat 130 MG tablet 14S (SPE2D326F117S), from Medical Supply Chain, on May 13, 2026.

On GovTribe

See Anbex Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors